condylomata acuminata

Summary

Summary: Sexually transmitted form of anogenital warty growth caused by the human papillomaviruses.

Top Publications

  1. Gertig D, Brotherton J, Saville M. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia. Sex Health. 2011;8:171-8 pubmed publisher
    ..Future monitoring of vaccine effectiveness will be facilitated by cross-linking to Pap test registries. ..
  2. Fairley C, Donovan B. What can surveillance of genital warts tell us?. Sex Health. 2010;7:325-7 pubmed publisher
    ..However, if genital warts stabilise at a lower, but not very low, rate we will know that elimination will not be possible without vaccination of males. ..
  3. Lanitis T, Carroll S, O Mahony C, Charman F, Khalid J, Griffiths V, et al. The cost of managing genital warts in the UK. Int J STD AIDS. 2012;23:189-94 pubmed publisher
    ..Using treatment patterns obtained from key opinion leaders and tariffs from National Health Service Payment by Results (NHS PbR), the national costs were estimated at £52.4 million: £276 per treated GW episode. ..
  4. Hartwig S, Syrjanen S, Dominiak Felden G, Brotons M, Castellsague X. Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review. BMC Cancer. 2012;12:30 pubmed publisher
    ..The objective of this review is to estimate the epidemiological burden of HPV-related cancers and non-malignant diseases in men in Europe...
  5. Cao Y, Zhao J, Yang Z, Cai Z, Zhang B, Zhou Y, et al. CD4+FOXP3+ regulatory T cell depletion by low-dose cyclophosphamide prevents recurrence in patients with large condylomata acuminata after laser therapy. Clin Immunol. 2010;136:21-9 pubmed publisher
    b>Condylomata acuminata (CA) caused by human papillomavirus (HPV) is a common sexually transmitted disease with half a million new cases diagnosed in the United States per year and the annual increase in incidence in China...
  6. Pirotta M, Stein A, Conway E, Harrison C, Britt H, Garland S. Genital warts incidence and healthcare resource utilisation in Australia. Sex Transm Infect. 2010;86:181-6 pubmed publisher
    ..To estimate for the first time the incidence and healthcare resource utilisation associated with genital warts (GW) in Australia prior to the human papillomavirus vaccination programme...
  7. Weyandt G, Tollmann F, Kristen P, Weissbrich B. Low risk of contamination with human papilloma virus during treatment of condylomata acuminata with multilayer argon plasma coagulation and CO? laser ablation. Arch Dermatol Res. 2011;303:141-4 pubmed publisher
    ..In conclusion, both CO? laser ablation with plume suction and APC treatment seem to have a low risk of HPV contamination of the operation room...
  8. Low A, Didelot Rousseau M, Nagot N, Ouedraougo A, Clayton T, Konate I, et al. Cervical infection with human papillomavirus (HPV) 6 or 11 in high-risk women in Burkina Faso. Sex Transm Infect. 2010;86:342-4 pubmed publisher
    ..Human papillomavirus (HPV) types 6 and 11 are known agents of genital warts but little is known about their epidemiology in Africa...
  9. Skaaby S, Kofoed K. Anogenital warts in Danish men who have sex with men. Int J STD AIDS. 2011;22:214-7 pubmed publisher
    ..If a free HPV vaccine were to be offered, 94.4% would like to receive it. These data suggest a high prevalence of AGWs in Danish MSM. The awareness of HPV is low; however, the acceptance of a HPV vaccine seems high...

More Information

Publications67

  1. Raymakers A, Sadatsafavi M, Marra F, Marra C. Economic and humanistic burden of external genital warts. Pharmacoeconomics. 2012;30:1-16 pubmed publisher
    ..Our study also highlights the dearth of information on the impact of EGW on the QOL and productivity of patients...
  2. Lin C, Lau J, Ho K, Lau M, Tsui H, Lo K. Incidence of genital warts among the Hong Kong general adult population. BMC Infect Dis. 2010;10:272 pubmed publisher
    ..The objective of this study is to estimate the incidence of genital warts in Hong Kong and explore a way to establish a surveillance system for genital warts among the Hong Kong general population...
  3. McRee A, Reiter P, Chantala K, Brewer N. Does framing human papillomavirus vaccine as preventing cancer in men increase vaccine acceptability?. Cancer Epidemiol Biomarkers Prev. 2010;19:1937-44 pubmed publisher
    ..We conducted an experiment to see whether framing HPV vaccination as also preventing cancer in men would increase men's vaccination willingness...
  4. Kim J. Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis. Lancet Infect Dis. 2010;10:845-52 pubmed publisher
    ..High-risk populations such as men who have sex with men (MSM) might especially benefit from vaccination. I aimed to estimate the cost-effectiveness of HPV vaccination of MSM in the USA...
  5. Weiss T, Zimet G, Rosenthal S, Brenneman S, Klein J. Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females. J Adolesc Health. 2010;47:3-11 pubmed publisher
    ..We assessed U.S. physicians' attitudes and perceptions regarding potential human papillomavirus (HPV) vaccination of males...
  6. Drolet M, Brisson M, Maunsell E, Franco E, Coutlee F, Ferenczy A, et al. The impact of anogenital warts on health-related quality of life: a 6-month prospective study. Sex Transm Dis. 2011;38:949-56 pubmed publisher
    ..We conducted a multicenter prospective study to (1) describe the impact of anogenital warts on quality of life and (2) estimate the quality-adjusted life-years (QALYs) lost due to anogenital warts...
  7. Winder D, Ball S, Vaughan K, Hanna N, Woo Y, Fränzer J, et al. Sensitive HPV detection in oropharyngeal cancers. BMC Cancer. 2009;9:440 pubmed publisher
    ..To help ascertain a useful PCR detection protocol for oropharyngeal cancers, we directly compared three commonly used primer sets in detection of HPV from different clinical samples...
  8. Fairley C, Hocking J, Gurrin L, Chen M, Donovan B, Bradshaw C. Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women. Sex Transm Infect. 2009;85:499-502 pubmed publisher
    ..This study aimed to determine if the Australian human papillomavirus (HPV) vaccination programme has had a population impact on presentations of genital warts...
  9. Leval A, Herweijer E, Arnheim Dahlström L, Walum H, Frans E, Sparen P, et al. Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability. J Infect Dis. 2012;206:860-6 pubmed publisher
    ..The introduction of HPV vaccines necessitates the estimation of the population-based incidence of GW immediately before and after vaccination uptake...
  10. Flagg E, Schwartz R, Weinstock H. Prevalence of anogenital warts among participants in private health plans in the United States, 2003-2010: potential impact of human papillomavirus vaccination. Am J Public Health. 2013;103:1428-35 pubmed publisher
    ..We estimated anogenital wart prevalence from 2003 to 2010 by gender and age group in a large US cohort with private insurance to detect potential decreases among people most likely to be affected by human papillomavirus (HPV) vaccination...
  11. Scarbrough Lefebvre C, Van Kriekinge G, Goncalves M, de Sanjose S. Appraisal of the burden of genital warts from a healthcare and individual patient perspective. Public Health. 2011;125:464-75 pubmed publisher
    ..The purpose of this study was therefore to investigate the epidemiological, economic and quality of life (QoL) burden of genital warts...
  12. Arima Y, Winer R, Feng Q, Hughes J, Lee S, Stern M, et al. Development of genital warts after incident detection of human papillomavirus infection in young men. J Infect Dis. 2010;202:1181-4 pubmed publisher
    ..7% (95% CI, 0.2%-2.8%) among 331 men who tested negative for HPV. Our results suggest that genital warts are common after HPV-6 or HPV-11 infection in young men...
  13. Jeynes C, Chung M, Challenor R. 'Shame on you'--the psychosocial impact of genital warts. Int J STD AIDS. 2009;20:557-60 pubmed publisher
    ..0001) were significant in predicting HRQoL scores. There are emotional implications in having genital warts, which can have a profound effect on a patient's quality of life and these need addressing just as much as the physical warts...
  14. Baandrup L, Blomberg M, Dehlendorff C, Sand C, Andersen K, Kjaer S. Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program. Sex Transm Dis. 2013;40:130-5 pubmed publisher
    ..We determined the incidence of GWs in Denmark since 1996, focusing on the period after licensing of HPV vaccination (October 2006)...
  15. Ezat S, Aljunid S. Comparative cost-effectiveness of HPV vaccines in the prevention of cervical cancer in Malaysia. Asian Pac J Cancer Prev. 2010;11:943-51 pubmed
    ..A scenario based sensitivity analysis was conducted using screening population coverages (40-80%) and costs of vaccines (RM 100-200/dose) were calculated...
  16. Herse F, Reissell E. The annual costs associated with human papillomavirus types 6, 11, 16, and 18 infections in Finland. Scand J Infect Dis. 2011;43:209-15 pubmed publisher
    ..Therefore, we undertook this study to estimate the burden and costs associated with HPV-related diseases...
  17. Demarteau N, Standaert B. Modelling the economic value of cross- and sustained-protection in vaccines against cervical cancer. J Med Econ. 2010;13:324-38 pubmed publisher
    ..Two human papillomavirus (HPV) vaccines are on the market. Based on expected differences in sustained- and cross-protection between the two vaccines, their long-term economic value is modelled and compared for France, Ireland and Italy...
  18. Ball S, Winder D, Vaughan K, Hanna N, Levy J, Sterling J, et al. Analyses of human papillomavirus genotypes and viral loads in anogenital warts. J Med Virol. 2011;83:1345-50 pubmed publisher
    b>Condylomata acuminata (genital warts) are the most common sexually transmitted viral diseases. These lesions are caused by infection with mucosal human papillomaviruses (HPVs)...
  19. Woodhall S, Jit M, Soldan K, Kinghorn G, Gilson R, Nathan M, et al. The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK. Sex Transm Infect. 2011;87:458-63 pubmed publisher
    ..To estimate the loss of quality of life and cost of treatment associated with genital warts seen in sexual health clinics...
  20. Brisson M, Van de Velde N, Franco E, Drolet M, Boily M. Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity. J Infect Dis. 2011;204:372-6 pubmed publisher
    ..Given the important predicted herd immunity impact of vaccinating girls under moderate to high vaccine coverage, the potential incremental gains of vaccinating boys are limited...
  21. Howell Jones R, Soldan K, Wetten S, Mesher D, Williams T, Gill O, et al. Declining genital Warts in young women in england associated with HPV 16/18 vaccination: an ecological study. J Infect Dis. 2013;208:1397-403 pubmed publisher
    ..However, from 2009 to 2011 there were decreases in reported diagnoses of GW in young females at GUM clinics...
  22. Blomberg M, Dehlendorff C, Munk C, Kjaer S. Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark. Clin Infect Dis. 2013;57:929-34 pubmed publisher
    ..The aim of this cohort study was to use individual information on HPV vaccination status to assess the effect on risk of GWs...
  23. Patel H, Wagner M, Singhal P, Kothari S. Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis. 2013;13:39 pubmed publisher
    ..Because of the lack of a systematic review of the epidemiology of AGWs in the literature, this study reviewed the published medical literature on the incidence and prevalence of AGWs...
  24. Insinga R, Dasbach E, Elbasha E. Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect Dis. 2009;9:119 pubmed publisher
    ..S. population context; (2) Identify areas where additional studies are particularly needed...
  25. Blomberg M, Friis S, Munk C, Bautz A, Kjaer S. Genital warts and risk of cancer: a Danish study of nearly 50 000 patients with genital warts. J Infect Dis. 2012;205:1544-53 pubmed publisher
    ..We conducted a large national cohort study to examine the risk of cancer among men and women with genital warts (GW)...
  26. Anic G, Lee J, STOCKWELL H, Rollison D, Wu Y, Papenfuss M, et al. Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: the HPV in men study. J Infect Dis. 2011;204:1886-92 pubmed publisher
    ..We described the distribution of HPV types in incident GWs and estimated GW incidence and time from type-specific incident HPV infections to GW detection in a multinational cohort of men aged 18-70 years...
  27. Brewer N, Ng T, McRee A, Reiter P. Men's beliefs about HPV-related disease. J Behav Med. 2010;33:274-81 pubmed publisher
    ..Many men were unaware that HPV infection can cause genital warts, oral cancer, and anal cancer...
  28. Woodhall S, Eriksson T, Nykänen A, Huhtala H, Rissanen P, Apter D, et al. Impact of HPV vaccination on young women's quality of life - a five year follow-up study. Eur J Contracept Reprod Health Care. 2011;16:3-8 pubmed publisher
    ..We investigated the impact of HPV infection on QoL five years post vaccination in 22-23 year-old women and a group of controls...
  29. Elbasha E, Dasbach E. Impact of vaccinating boys and men against HPV in the United States. Vaccine. 2010;28:6858-67 pubmed publisher
    ..Vaccinating boys and men age 9-26 against all HPV 6/11/16/18-associated diseases provides substantial public health benefits and is cost-effective at commonly cited thresholds...
  30. Jiménez Vieyra C. [Prevalence of condyloma acuminata in women who went to opportune detection of cervicouterine cancer]. Ginecol Obstet Mex. 2010;78:99-102 pubmed
    ..It has been considered the incidence and the prevalence of the disease of sexual transmission with base in the different data banks. Unfortunately, each of these sources has limitations...
  31. Dillner J, Kjaer S, Wheeler C, Sigurdsson K, Iversen O, Hernandez Avila M, et al. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ. 2010;341:c3493 pubmed publisher
    ..To evaluate the prophylactic efficacy of the human papillomavirus (HPV) quadrivalent vaccine in preventing low grade cervical, vulvar, and vaginal intraepithelial neoplasias and anogenital warts (condyloma acuminata)...
  32. Sánchez D, Pathela P, Niccolai L, Schillinger J. Knowledge of human papillomavirus and anal cancer among men who have sex with men attending a New York City sexually transmitted diseases clinic. Int J STD AIDS. 2012;23:41-3 pubmed publisher
    ..05; CI = 0.01, 0.29). Nearly all expressed hypothetical acceptance of HPV vaccine. In our sample, many MSM were unaware of a link between MSM sexual practices and HPV-related outcomes...
  33. Brotherton J, Heywood A, Heley S. The incidence of genital warts in Australian women prior to the national vaccination program. Sex Health. 2009;6:178-84 pubmed publisher
    ..A surveillance system capable of documenting any decrease in the incidence of genital warts and recurrent respiratory papillomatosis after vaccination is urgently required...
  34. Giuliano A, Lee J, Fulp W, Villa L, Lazcano E, Papenfuss M, et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet. 2011;377:932-40 pubmed publisher
    ..The goal in this study was to estimate incidence and clearance of type-specific genital HPV infection in men, and to assess the associated factors...
  35. Bauer H, Wright G, Chow J. Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007-2010. Am J Public Health. 2012;102:833-5 pubmed publisher
    ..The diagnoses stabilized or increased among older age groups. HPV vaccine may be preventing GW among young people...
  36. Oliphant J, Perkins N. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services. N Z Med J. 2011;124:51-8 pubmed
    ..Monitoring rates of diagnosis of genital warts should provide the earliest clinical indicator of a population response to the vaccine...
  37. Kraut A, Schink T, Schulze Rath R, Mikolajczyk R, Garbe E. Incidence of anogenital warts in Germany: a population-based cohort study. BMC Infect Dis. 2010;10:360 pubmed publisher
    ..Additionally, the medical practitioner (gynaecologist, dermatologist, urologist etc.) who made the initial diagnosis of AGW was assessed...
  38. Komlos K, Kocjan B, Kosorok P, Luzar B, Meglic L, Potocnik M, et al. Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens. J Med Virol. 2012;84:1233-41 pubmed publisher
    ..0% vs. 59.2%; P?=?0.000013), whereas HPV-11 was statistically more frequent in laryngeal papillomas than in anogenital warts (28.9% vs. 12.4%; P?=?0.00003)...
  39. Tzellos T, Sardeli C, Lallas A, Papazisis G, Chourdakis M, Kouvelas D. Efficacy, safety and tolerability of green tea catechins in the treatment of external anogenital warts: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2011;25:345-53 pubmed publisher
    ..Current treatments are unsatisfactory. Green tea sinecatechin Polyphenon E ointment is a botanical extract from green tea leaves exhibiting anti-oxidant, anti-viral and anti-tumour properties...
  40. Ali H, Donovan B, Wand H, Read T, Regan D, Grulich A, et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ. 2013;346:f2032 pubmed publisher
    ..To measure the effect on genital warts of the national human papillomavirus vaccination programme in Australia, which started in mid-2007...
  41. Müller E, Chirwa T, Lewis D. Human papillomavirus (HPV) infection in heterosexual South African men attending sexual health services: associations between HPV and HIV serostatus. Sex Transm Infect. 2010;86:175-80 pubmed publisher
  42. Donovan B, Franklin N, Guy R, Grulich A, Regan D, Ali H, et al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis. 2011;11:39-44 pubmed publisher
    ..We established a national surveillance network in Australia and aimed to identify trends in diagnoses of genital warts in 2004-09...
  43. Ali H, Guy R, Wand H, Read T, Regan D, Grulich A, et al. Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program. BMC Infect Dis. 2013;13:140 pubmed publisher
    ..We assessed the impact of the vaccination program on the number of in-patient treatments for genital warts...
  44. Lee C, Choe H, Hwang S, Lee S, Cho Y. Epidemiological characteristics of genital herpes and condyloma acuminata in patients presenting to urologic and gynecologic clinics in Korea. J Infect Chemother. 2011;17:351-7 pubmed publisher
  45. Pitts M, Heywood W, Ryall R, Smith A, Shelley J, Richters J, et al. Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women. Sex Health. 2010;7:299-303 pubmed publisher
    ..The present study investigated HPV knowledge after the introduction of a national HPV vaccination program in Australia using a national sample of men and women...
  46. Read T, Hocking J, Chen M, Donovan B, Bradshaw C, Fairley C. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect. 2011;87:544-7 pubmed publisher
    ..Australia provided free quadrivalent human papillomavirus vaccines to 12-18-year-old girls and women aged ?26 years from mid-2007 until the end of 2009. After this time, only girls aged 12-13 years had access to free vaccines...
  47. Jit M, Chapman R, Hughes O, Choi Y. Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model. BMJ. 2011;343:d5775 pubmed publisher
  48. Brotherton J, Kaldor J, Garland S. Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy. Sex Health. 2010;7:310-9 pubmed publisher
    ..Australia is well placed to monitor the impact of its HPV vaccination program as well as to measure vaccine effectiveness with existing HPV vaccines, cervical screening and cancer registries...
  49. Palefsky J. Human papillomavirus-related disease in men: not just a women's issue. J Adolesc Health. 2010;46:S12-9 pubmed publisher
    ..Other HPV-related diseases of clinical importance in men include condylomata acuminata (genital warts) and recurrent respiratory papillomatosis...
  50. Garnock Jones K, Giuliano A. Quadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine: for the prevention of genital warts in males. Drugs. 2011;71:591-602 pubmed publisher
    ..The quadrivalent HPV vaccine was generally well tolerated in males aged 9-26 years. The most common adverse events reported were injection-site related, and most of these were of mild to moderate severity...
  51. Desai S, Wetten S, Woodhall S, Peters L, Hughes G, Soldan K. Genital warts and cost of care in England. Sex Transm Infect. 2011;87:464-8 pubmed publisher
    ..To estimate the total number of cases of, and cost of care for, genital warts (GWs) in England, to inform economic evaluations of human papillomavirus vaccination...
  52. Menton J, Cremin S, Canier L, Horgan M, Fanning L. Molecular epidemiology of sexually transmitted human papillomavirus in a self referred group of women in Ireland. Virol J. 2009;6:112 pubmed publisher
    ..Positive samples were then genotyped by means of a commercially available assay (LiPA). A comparison of genotyping results determined by the LiPA assay and direct amplicon DNA sequencing was also performed...
  53. Mikolajczyk R, Kraut A, Horn J, Schulze Rath R, Garbe E. Changes in incidence of anogenital warts diagnoses after the introduction of human papillomavirus vaccination in Germany-an ecologic study. Sex Transm Dis. 2013;40:28-31 pubmed publisher
    ..0001). The decrease started between the first and second quarter of 2007 (human papillomavirus vaccination was introduced in March 2007)...
  54. Mi X, Chai W, Zheng H, Zuo Y, Li J. A randomized clinical comparative study of cryotherapy plus photodynamic therapy vs. cryotherapy in the treatment of multiple condylomata acuminata. Photodermatol Photoimmunol Photomed. 2011;27:176-80 pubmed publisher
    Cryotherapy cannot destroy subclinical human papillomavirus-infected cells of condylomata acuminata (CA). The topical application of aminolevulinic acid (ALA) results in a shallow penetration depth in CA lesions (1).
  55. Mortensen G, Larsen H. The quality of life of patients with genital warts: a qualitative study. BMC Public Health. 2010;10:113 pubmed publisher
    ..Very few studies have been performed on the personal consequences of genital warts. The aim of this qualitative study, set in Denmark, was to examine the ways in which genital warts may affect patients' quality of life...
  56. Wang S, Shi J, Kang D, Song P, Qiao Y. Impact of human papillomavirus-related lesions on quality of life: a multicenter hospital-based study of women in Mainland China. Int J Gynecol Cancer. 2011;21:182-8 pubmed publisher
    ..To date, few studies using a human papillomavirus (HPV)-specific questionnaire have focused on the impact of quality of life (QoL) among women with HPV-related lesions in developing countries...
  57. Diamantis M, Bartlett B, Tyring S. Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts. Skin Therapy Lett. 2009;14:1-3, 5 pubmed
    ..Imiquimod 5% cream showed an acceptable safety profile; local inflammatory reactions were the most frequent adverse effects, with local erythema being the most common...
  58. Mortensen G. Long-term quality of life effects of genital warts - a follow-study. Dan Med Bull. 2010;57:A4140 pubmed
    ..This follow-up study is the first of its kind to explore the possible physical and psycho-sexual long-term effects of having previously had GW...